Transient regression in lymphocyte count in B-cell chronic lymphocytic leukemia after viral infection

K Shirono1, M Ikebe, T Inada

  • 1Division of Clinical Hematology and Immunology, Kumamoto City Hospital, Japan.

Acta Haematologica
|January 1, 1995
PubMed

Insights

Viral infections and interferon-alpha (IFN-alpha) treatments can cause temporary lymphocyte count drops in B-cell chronic lymphocytic leukemia (B-CLL) patients. This regression is not due to direct cell death or growth inhibition by IFN-alpha.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a common lymphoid malignancy.
  • Understanding factors influencing lymphocyte counts in B-CLL is crucial for disease management.

Observation:

  • A transient decrease in lymphocyte count was observed in a B-CLL patient following a viral infection.
  • A similar lymphocyte count regression occurred during natural interferon-alpha (IFN-alpha) treatment.

Findings:

  • Interferon-alpha (IFN-alpha) was investigated for its role in lymphocyte count reduction.
  • DNA fragmentation analysis ruled out direct cytotoxic effects (apoptosis, necrosis) of IFN-alpha on lymphocytes.
  • The study suggests IFN-alpha does not exert a cytostatic effect leading to lymphocyte count regression.

Implications:

  • These findings suggest a non-cytotoxic, non-cytostatic mechanism for IFN-alpha-induced lymphocyte count changes in B-CLL.
  • Further research is needed to elucidate the precise mechanism behind this transient regression.
  • This understanding may inform therapeutic strategies and monitoring in B-CLL patients.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...